Aggravation of vasogenic cerebral edema by multiple-dose mannitol

Journal of Neurosurgery - Tập 77 Số 4 - Trang 584-589 - 1992
Anthony M. Kaufmann1, Érico R. Cardoso
1Cerebral Hydrodynamics Laboratory, University of Manitoba, Winnipeg, Canada.

Tóm tắt

✓ The authors investigated the pharmacokinetics of mannitol administered for treatment of vasogenic cerebral edema. A cortical cold injury was produced in 23 cats maintained under general anesthesia for 5 or 21 hours. Control animals received no mannitol, while treatment groups received either a single dose or five doses administered at 4-hour intervals of 0.33 gm/kg radiolabeled mannitol. Liquid scintillation counting was carried out to determine the concentrations of mannitol in the cerebral tissue, cerebrospinal fluid, plasma, and urine. Cerebral water content and linear progression of edema were also measured. Rapid plasma clearance prevented accumulation of mannitol after multiple intravenous injections, as 84% ± 2% (mean ± standard error of the mean) of the infused mannitol was excreted through the urine. However, there was progressive accumulation of mannitol within the cerebral tissue, especially in the edematous white matter where it reached a level of 0.33 ± 0.03 mg/gm after five doses, exceeding the trough plasma concentrations by a ratio of 2.69:1. Water content measurement showed that a single dose of mannitol failed to reduce cerebral water content or edema progression at 4 hours postinjection, while multiple doses produced a 3% increase in water content in edematous regions (p > 0.0003). The results of this study demonstrated a reversal of the osmotic concentration gradient between edematous brain and plasma following multiple mannitol injections, associated with exacerbation of vasogenic cerebral edema.

Từ khóa


Tài liệu tham khảo

10.3171/jns.1984.60.3.0481

Anderson P, 1988, Eur J Clin Pharmacol, 35, 643, 10.1007/BF00637601

10.3171/jns.1977.47.4.0491

Bellegarrigue R, 1983, Intracranial Pressure V., 567, 10.1007/978-3-642-69204-8_97

Blomquist CH, 1981, J Clin Chem Clin Biochem, 19, 139

10.3171/jns.1973.38.2.0131

Bruce DA, 1976, Dynamics of Brain Edema., 122, 10.1007/978-3-642-66524-0_21

Cascino T, 1983, Neurology, 33, 898, 10.1212/WNL.33.7.898

Cloyd JC, 1986, J Pharmacol Exp Ther, 236, 301

10.1016/0022-510X(84)90067-4

Harbaugh RD, 1979, Neurosurgery, 5, 656, 10.1227/00006123-197912000-00002

10.1007/BF01405391

Jennett B, 1980, J Neurol Neurosurg Psychiatry, 43, 289, 10.1136/jnnp.43.4.289

Johnston IH, 1970, Lancet, 2, 433, 10.1016/S0140-6736(70)90054-1

10.1097/00005072-196701000-00001

Klatzo I, 1965, Prog Brain Res, 15, 73, 10.1016/S0079-6123(08)60940-1

Levin VA, 1970, Am J Physiol, 219, 1528, 10.1152/ajplegacy.1970.219.5.1528

Long DM, 1972, Steroids and Brain Edema., 87, 10.1007/978-3-642-65448-0_9

10.3171/jns.1978.49.4.0530

10.3171/jns.1982.56.2.0246

10.3171/jns.1978.48.2.0169

10.3171/jns.1979.50.1.0020

10.1097/00006123-198309000-00009

10.3171/jns.1985.63.1.0043

10.3171/jns.1984.61.4.0700

10.3171/jns.1983.59.5.0822

10.3171/jns.1986.65.1.0041

Nelson SR, 1971, J Appl Physiol, 30, 268, 10.1152/jappl.1971.30.2.268

Ohno K, 1978, Am J Physiol, 235, H299

10.3171/jns.1974.41.5.0531

Pappius HM, 1967, Brain Edema., 445, 10.1007/978-3-7091-7545-3_31

10.1001/archneur.1965.00470040061010

Ravussin P, 1980, J Neurosurg, 64, 104, 10.3171/jns.1986.64.1.0104

Rosenberg GA, 1978, Trans Am Neurol, 103, 240

10.1097/00006123-198708000-00003

10.3171/jns.1982.56.4.0498

Siemkowicz E, 1981, Acta Physiol Scand, 112, 359, 10.1111/j.1748-1716.1981.tb06831.x

10.3171/jns.1986.65.6.0820

Takagi H, 1983, Intracranial Pressure V., 729, 10.1007/978-3-642-69204-8_125

Van Harreveld A, 1966, Brain Tissue Electrolytes.

10.1016/0014-4886(64)90067-6